spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  POLAR 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 13 Jan 2025
Medtronic Achieves CE Mark Approval for BrainSense Adaptive Deep Brain Stimulation and Electrode Identifier, a Groundbreaking Advance In Personalized, Sensing-Enabled Care for People with Parkinson's Through Innovative Brain-Computer Interface Technology
Devices Neurosurgery Regulatory
 HSMN NewsFeed - 18 Apr 2024
Pathios Therapeutics Raises $25M in First Close of Series B Financing to Advance First-in-Class Immunotherapy Approach into Clinic
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Feb 2024
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 5 Jan 2024
Vico Therapeutics Announces $60 million (€54 million) Series B Financing to Advance VO659 Clinical-Stage Program for Rare Neurological Diseases and Expand Pipeline
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 31 Aug 2023
Casio to Release Uterocervical Observation Camera and Camera Stand in Europe
Devices Product Launch
 HSMN NewsFeed - 30 Aug 2023
Alkermes Announces Settlement With Teva Related to VIVITROL(R) Patent Litigation
Biopharmaceuticals Litigation Licensing
 HSMN NewsFeed - 7 Aug 2023
NRx Pharmaceuticals Announces the Licensure of a US Patent to Support Use of NRX-101(TM) for Chronic Pain
Biopharmaceuticals Licensing
 HSMN NewsFeed - 9 Mar 2023
QurAlis Closes $88 Million Series B Financing to Advance Precision Medicines for Neurodegenerative Diseases
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 6 Feb 2023
Candela Introduces the New FDA-Cleared Profound Matrix(TM) System
Devices Dermatology FDA Product Launch
 HSMN NewsFeed - 5 Dec 2022
NRx Pharmaceuticals Announces the Appointment of Carrie M. Carretta, PhD, APN-BC, AHN-BC, PMHNP, Senior Vice President of Clinical Development and Medical Affairs
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 15 Nov 2022
Jnana Therapeutics Raises $107 Million to Advance Lead PKU Program and Progress Therapeutics Pipeline Discovered by the RAPID Platform
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Oct 2022
Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System
Devices Cardiology FDA
 HSMN NewsFeed - 28 Sep 2022
Olympus Launches THUNDERBEAT Energy Device for Open Surgery
Devices Surgery Product Launch
 HSMN NewsFeed - 7 Sep 2022
Serpex Medical Announces Second FDA 510(k) Clearance of its Steerable Endobronchial Instrument Platform - The Compass Steerable Needle
Devices FDA
 HSMN NewsFeed - 28 Mar 2022
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi(R) (solriamfetol) to Axsome Therapeutics
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 18 Mar 2022
NRx Pharmaceuticals, Inc. Appoints Ira Strassberg as Chief Financial Officer and Treasurer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2022
Advanced Oxygen Therapy: Announcing Key Leadership Team Additions and Scientific Clinical Advisory Board Formation
Devices Wound Care Personnel
 HSMN NewsFeed - 4 Feb 2022
Regenerative Patch Technologies Presents Clinical Data Demonstrating Long-Term Survival and Function of an Allogenic Bioengineered Cellular Implant in Patients with Advanced Dry Aged-Related Macular Degeneration
Regenerative Medicine Ophthalmology
 HSMN NewsFeed - 12 Jan 2022
Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 23 Dec 2021
Healis Therapeutics announces mission to deliver new class of neuromuscular treatments in psychiatry
Biopharmaceuticals
 HSMN NewsFeed - 17 Aug 2021
Smith & Nephew expands its leading WEREWOLF(TM) Technology into total joint arthroplasty with launch of WEREWOLF FASTSEAL 6.0 Hemostasis Wand
Devices Orthopaedic Surgery Product Launch
 HSMN NewsFeed - 2 Aug 2021
Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Jul 2021
Corium Launches Innovative ADHD Treatment AZSTARYS(TM) (serdexmethylphenidate and dexmethylphenidate) in the U.S. for Patients Age 6 Years and Older
Biopharmaceutical Neurology Product Launch
 HSMN NewsFeed - 9 Jul 2021
Single Pass Closes Seed Funding Round
Devices Surgery Venture Capital
 HSMN NewsFeed - 21 Jun 2021
Ethicon Expands Advanced Biopolar Energy Portfolio With Launch Of ENSEAL X1 Curved Jaw Tissue Sealer
Devices Surgery Product Launch
 HSMN NewsFeed - 28 Apr 2021
Computer-guided surgery with Smith & Nephew's hip replacement implants shown to significantly improve survivorship and increase patient satisfaction compared to conventional surgery
Devices Orthopaedic
 HSMN NewsFeed - 14 Apr 2021
GlobalMed Introduces the TotalExam(R) Lite, the Next Generation of Digital General Exam Cameras and Otoscopes for Telemedicine
Devices Product Launch
 HSMN NewsFeed - 12 Mar 2021
Cardinal Health Signs Definitive Agreement to Sell its Cordis Business to Hellman & Friedman
Devices Cardiology Acquisitions
 HSMN NewsFeed - 11 Mar 2021
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Dec 2020
Polaryx Therapeutics Receives Both Rare Pediatric Disease and Orphan Drug Designations for the Treatment of Niemann Pick Disease Types A and B With PLX-300
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 16 Dec 2020
New data confirms Smith & Nephew technology as the best performing cementless construct for Total Hip Arthroplasty¹
Devices Orthopaedic
 HSMN NewsFeed - 13 Oct 2020
Dewpoint Therapeutics Appoints Ameet Nathwani as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Oct 2020
First Patients Treated with Galaxy Medical's Centauri(TM) Pulsed Electric Field Cardiac Ablation System
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Sep 2020
AbbVie Receives Orphan Drug and Fast Track Designations from the U.S. Food and Drug Administration for Elezanumab, an Investigational Monoclonal Antibody RGMa Inhibitor, for the Treatment of Spinal Cord Injury
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 21 Sep 2020
Relief and NeuroRx Announce Partnership for Global Commercialization of RLF-100(TM) and Selection of Commercial Partners
Biopharmaceuticals
 HSMN NewsFeed - 6 Aug 2020
FDA grants inhaled use IND for RLF-100 (aviptadil) to treat patients with moderate and severe COVID-19 aiming to prevent progression to respiratory failure
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 29 Jul 2020
Biotech Vico Therapeutics raises $31 million (€27 million) in Series A financing round to advance therapies for rare central nervous system diseases
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 18 Jun 2020
Smith & Nephew announces new milestone with its OXINIUM(TM) Advanced Bearing System implants surpassing two million procedures
Devices Orthopaedic
 HSMN NewsFeed - 1 Jun 2020
Boston Scientific Launches DIRECTSENSE(TM) Technology
Devices Cardiology Product Launch
 HSMN NewsFeed - 5 May 2020
Impel NeuroPharma Announces Leadership Transition, Chairman Adrian Adams' Role Expanded To Chairman And CEO
Biopharmaceuticals Drug Delivery Neurology Personnel
 HSMN NewsFeed - 25 Mar 2020
Kallyope Inc. Announces $112M Series C Financing to Support First Clinical Trials and Advance Portfolio of Programs Targeting the Gut-Brain Axis
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Mar 2020
Primmune Therapeutics Raises $7 Million Seed Financing to Develop Novel Oral TLR7 Immunotherapies for Cancer and Acute Viral Diseases
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 4 Feb 2020
Abbott's In-Development Fully Implantable Heart Pump System Earns FDA's Breakthrough Device Designation
Devices Cardiology FDA
 HSMN NewsFeed - 25 Nov 2019
INHIBITOR Therapeutics Submits Investigational New Drug Application for Treatment of Patients with Late-Stage Prostate Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Oct 2019
NeuroRx Secures HK$ 750 Million Capital Commitment From The Gem Group for Development of NRX-101
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Aug 2019
PIONYR Immunotherapeutics Announces Key Leadership Team Addition and Clinical Candidates Targeting Tumor-Associated Macrophages
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Aug 2019
Corinth MedTech Appoints Steven Duddy as New President and CEO
Devices Urology Personnel
 HSMN NewsFeed - 30 Jul 2019
Alfa Plus by Solio Receives FDA Clearance: Unique Device Delivers Pain Relief Without Pharmaceuticals
Devices FDA Product Launch
 HSMN NewsFeed - 15 Jul 2019
Alkermes Expands Planned New Drug Application for ALKS 3831 to Include Treatment of Bipolar I Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Jun 2019
PolarityTE Creates Office of the Chief Executive to Focus on Commercialization and Operational Performance
Regenerative Medicine Personnel
 HSMN NewsFeed - 30 May 2019
U.S. FDA Approves Supplemental New Drug Application Adding Overall Survival Data for XOSPATA(R) (gilteritinib)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 13 May 2019
Smith & Nephew launches new FLOW 90(TM) Wand at ISAKOS joining its innovative collection of COBLATION(TM) technology and shoulder repair portfolios
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 10 May 2019
PolarityTE Announces Clinical Data from Two Studies Showing 12-Week Closure of Difficult-to-Treat Lower Extremity Chronic Wounds Using SkinTE
Regenerative Medicine Wound Care
 HSMN NewsFeed - 29 Mar 2019
PolarityTE Announces Richard Hague, Formerly from Sanofi, Genzyme and Recently Anika Therapeutics as Chief Operating Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 28 Dec 2018
PolarityTE Registers OsteoTE(TM) with U.S. Food and Drug Administration
Regenerative Medicine FDA
 HSMN NewsFeed - 23 Oct 2018
CavoGene LifeSciences Licenses Novel Gene Therapy for CNS Disorders
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 18 Oct 2018
PolarityTE(R) Announces Former Acelity Leader Sharon Whalen as Vice President of Market Access
Regenerative Medicine Personnel
 HSMN NewsFeed - 17 Oct 2018
Gauss raises $20 million in Series C from Northwell Health and SoftBank Ventures Korea for AI-Enabled Platform for the Operating Room
Devices Surgery Monitoring Venture Capital
 HSMN NewsFeed - 29 Aug 2018
Impel NeuroPharma Annouces First Subject Dosed In Phase 1 Trial Evaluating INP105 For The Treatment Of Acute Agitation In Bipolar I Disorder And Schizophrenia
Biopharmaceuticals Drug Delivery Neurology
 HSMN NewsFeed - 8 Aug 2018
SQZ Biotech Completes Oversubscribed $72 Million Series C Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 9 Jul 2018
Polaris Announces Drs. James Allison and Padmanee Sharma Joining its Scientific Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Jun 2018
Impel NeuroPharma Announces FDA Clearance of IND for Pivotal Phase 3 Study of INP104 for Acute Treatment of Migraine
Biopharmaceuticals Drug Delivery Neurology FDA
 HSMN NewsFeed - 31 May 2018
Encision Inc. Applauds the FDA's Safety Communication On The Dangers Of Monopolar Electrosurgery
Devices Surgery FDA
 HSMN NewsFeed - 30 May 2018
Olympus Launches the DualKnife J, an ESD Electrosurgical Knife That Shortens Procedure Time
Devices Gastroenterology Product Launch
 HSMN NewsFeed - 28 May 2018
Luye Pharma Acquires AstraZeneca's Signature Products Seroquel and Seroquel XR
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 29 Mar 2018
TAP Blood Collection Device Receives CE Mark
Devices Regulatory
 HSMN NewsFeed - 22 Feb 2018
Kallyope Inc. Announces $66M Series B Financing to Advance Programs Targeting the Gut-Brain Axis
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 6 Feb 2018
eNeura, Inc. Announces Series D Financing
Devices Neurology Venture Capital
 HSMN NewsFeed - 27 Dec 2017
NeuroRx Signs Agreement With U.S. Dept. of Veterans Affairs and Baylor College of Medicine for Clinical Trial of First Drug Regimen Targeting Severe Bipolar Depression in Patients With Acute Suicidal Ideation & Behavior (ASIB)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Dec 2017
Polaryx Therapeutics Receives Orphan Drug Designation From the US FDA for the Treatment of Neuronal Ceroid Lipofuscinoses With PLX-100
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 7 Dec 2017
Metacrine Completes Series B Financing to Advance Best-in-Class FXR Program into Clinical Development
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 21 Nov 2017
Sumitomo Dainippon Pharma and Angelini Announce Partnership for Commercialization of Latuda(R) (Lurasidone Hydrochloride) in Europe
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 13 Nov 2017
Allergan Receives FDA Approval For Use of VRAYLAR(TM) (cariprazine) in the Maintenance Treatment of Schizophrenia
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 5 Oct 2017
Neurocrine Announces FDA Approval of 80 mg INGREZZA(R) (valbenazine) Capsules for the Treatment of Adults with Tardive Dyskinesia (TD)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 7 Sep 2017
eNeura, Inc. Receives FDA Clearance for Use of SpringTMS(R) for Migraine Prevention
Devices Neurology FDA
 HSMN NewsFeed - 6 Sep 2017
NeuroRx Awarded FDA Fast Track Designation for First Drug Regimen Targeting Suicide in Bipolar Depression
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Aug 2017
BIOTRONIK US Launches Smallest MR Conditional Quadripolar Cardiac Resynchronization Therapy Pacemaker
Devices Cardiology FDA Product Launch
 HSMN NewsFeed - 10 May 2017
Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers
Devices Cardiology Radiology FDA
 HSMN NewsFeed - 4 May 2017
Olympus Extends Portfolio of EndoTherapy Solutions at DDW
Devices Gastroenterology Product Launch
 HSMN NewsFeed - 21 Apr 2017
Neurocrine Announces INGREZZA(TM) Long-Term Safety and Efficacy Data to be Presented at the 2017 American Academy of Neurology Annual Meeting
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Mar 2017
Bovie Medical Receives 510K Clearance for Its Cool-Coag(TM) Generator and Open Handpiece
Devices Surgery FDA
 HSMN NewsFeed - 23 Mar 2017
Revolutionary UroLift(R) System Launches in Ireland
Devices Urology Product Launch
 HSMN NewsFeed - 15 Mar 2017
OmniGuide Surgical Announces Commercial Launch of VELOCITY(TM) High Performance CO2 Laser Fiber
Devices Surgery Product Launch
 HSMN NewsFeed - 7 Mar 2017
Ethicon Launches ENSEAL(R) X1 Large Jaw Tissue Sealer, Establishing Next Generation Of Advanced Bipolar Devices
Devices Surgery Product Launch
 HSMN NewsFeed - 23 Feb 2017
First-Ever Device for Fast and Virtually Painless Blood Draw Receives FDA Clearance
Devices FDA
 HSMN NewsFeed - 13 Feb 2017
DePuy Synthes Launches ViviGen Formable(TM) Cellular Bone Matrix, Providing a New Cellular Allograft with Alternative Consistency for Spinal Fusion Surgery
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 11 Nov 2016
Sofregen Medical Acquires SERI(R) Surgical Scaffold Product Line from Allergan
Devices Surgery Acquisitions
 HSMN NewsFeed - 8 Nov 2016
Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Valeant for Contrave(R) (naltrexone HCl / bupropion HCl extended release) in Australia and New Zealand
Biopharmaceuticals Distribution
 HSMN NewsFeed - 7 Nov 2016
St. Jude Medical Gains CE Mark Approval for MRI Labeling of its Quadra Allure MP Cardiac Resynchronization Therapy Pacemaker
Devices Cardiology Radiology Regulatory
 HSMN NewsFeed - 4 Nov 2016
The GeneSight(R) Precision Medicine Test Drives Significant Medication Cost Savings in Patients with Generalized Anxiety Disorder
Diagnostics Personalized Medicine
 HSMN NewsFeed - 2 Nov 2016
HOYA Group PENTAX Medical Launch HemoStat WideCup(TM), The New Bipolar Hot Hemostasis Forceps Contributing to Early Treatment of Gastric Cancer
Devices Oncology Product Launch
 HSMN NewsFeed - 15 Sep 2016
Sofregen Medical Raises $6.2 Million in Series A Funding from Polaris Partners and Other Founding Investors
Devices Venture Capital
 HSMN NewsFeed - 16 Aug 2016
Bovie Medical Receives FDA 510(k) Clearance for Its PlazXact(TM) Ablator
Devices Orthopaedic Surgery FDA
 HSMN NewsFeed - 5 Aug 2016
Allergan and Richter Provide Update on Cariprazine Program
Biopharmaceuticals
 HSMN NewsFeed - 23 Jun 2016
St. Jude Medical Expands Its Heart Failure Portfolio with SyncAV CRT Technology, Providing Physicians Another Option for Managing Patients Not Responsive to Other Therapies
Devices Cardiology Regulatory Product Launch
 HSMN NewsFeed - 14 Jun 2016
Suneva Medical Closes $25 Million Financing To Support Continued Growth Opportunities
Devices Dermatology Venture Capital
 HSMN NewsFeed - 8 Jun 2016
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 16 May 2016
Neos Therapeutics Announces U.S. Launch of Adzenys XR-ODT(TM) (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients Six Years and Older
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 28 Apr 2016
Abbott to Acquire St. Jude Medical
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 21 Apr 2016
eNeura, Inc. Receives CE Mark Label Extension Expanding Use of SpringTMS(R) to Include Migraine Prevention
Devices Neurology Regulatory
 HSMN NewsFeed - 18 Apr 2016
St. Jude Medical Announces Launch and First US Implants of MultiPoint Pacing Technology
Devices Cardiology Product Launch
 HSMN NewsFeed - 16 Mar 2016
Allergan Announces U.S. Availability of VRAYLAR(TM) (cariprazine) for Treatment of Bipolar Mania and Schizophrenia in Adults
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 23 Feb 2016
Boston Scientific Receives U.S. FDA Approval For Quadripolar Leads And Initiates Global Trial To Expand MRI Labeling To The U.S. And Asia
Devices Cardiology FDA
 HSMN NewsFeed - 17 Feb 2016
Impax Receives FDA Approval for Generic Version of Adderall XR(R) (mixed salts of a single-entity amphetamine product) Capsules, CII
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 28 Jan 2016
Neos Therapeutics Announces FDA Approval of Adzenys XR-ODT(TM) (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients 6 Years and Older
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 11 Jan 2016
MedLumics Appoints Cardiovascular Device Expert Tim Lenihan to Board of Directors
Devices Cardiology Personnel
 HSMN NewsFeed - 7 Jan 2016
Alector Announces Closing of Series D Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 4 Jan 2016
Scholar Rock Announces $36 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Dec 2015
Navitor Pharmaceuticals Announces $33 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Oct 2015
Fate Therapeutics Announces Leadership Transition
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Sep 2015
Selecta Announces $38 Million Series E Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 Aug 2015
Editas Medicine Raises $120 Million to Advance Genome Editing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Aug 2015
Metacrine Raises $36 Million in Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 3 Aug 2015
Intra-Cellular Therapies Expands Leadership Team
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 23 Jul 2015
St. Jude Medical and Thoratec Announce Definitive Agreement
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 22 Jul 2015
Voyager Therapeutics Appoints Michael Higgins to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 11 Jun 2015
XTuit Pharmaceuticals Closes $22 Million Series A Financing to Advance Novel Microenvironmental Modulators for Cancers and Fibrotic Disorders
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 2 Apr 2015
Ethicon’s HARMONIC FOCUS(R)+ Shears Now Proven to Produce Vessel Seal Strength Equivalent to Advanced Bipolar Devices
Devices Surgery
 HSMN NewsFeed - 31 Mar 2015
Orthofix International Secures Option to Acquire eNeura, Inc.
Devices Neurology Mergers & Acquisitions
 HSMN NewsFeed - 16 Mar 2015
Vascular Solutions Launches PolarCath(TM) Peripheral Dilatation System
Devices Interventional Product Launch
 HSMN NewsFeed - 13 Mar 2015
Actavis Receives FDA Approval of SAPHRIS(R) for Pediatric Patients (age 10-17) for Acute Treatment of Manic or Mixed Episodes of Bipolar I Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Feb 2015
aTyr Pharma Receives EMA Orphan Drug Designation for Resolaris(TM) in FSHD
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 Dec 2014
Tal Medical Appoints Atul Pande, M.D., Former SVP and Head of Neurosciences at GSK, as Chief Medical Officer, EVP and SAB member
Devices Neurology Personnel
 HSMN NewsFeed - 17 Nov 2014
First U.S. Procedures Completed With The Symphion(TM) Hysteroscopic Tissue Removal System
Devices Product Launch
 HSMN NewsFeed - 30 Oct 2014
Hansen Medical Announces Global Launch of the Sensei X2(R) Robotic System
Devices Cardiology Product Launch
 HSMN NewsFeed - 27 Oct 2014
Syros Pharmaceuticals Closes $53 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Oct 2014
aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2014
Selecta Announces More than $20 Million in Equity Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Sep 2014
Intuitive Surgical Receives FDA Clearance for First Single-Site(R) Wristed Needle Driver for da Vinci(R) Si(R) Surgical System
Devices Surgery FDA
 HSMN NewsFeed - 3 Sep 2014
BIND Therapeutics Appoints Two New Board Members
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Aug 2014
Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Aug 2014
Seventh Sense Biosystems Closes $16 Million Series B Financing
Devices Diagnostics Venture Capital
 HSMN NewsFeed - 31 Jul 2014
Intra-Cellular Therapies Announces the Appointment of Michael Halstead as Senior Vice President and General Counsel
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 24 Jun 2014
Editas Medicine Appoints Katrine S. Bosley to Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jun 2014
Navitor Pharmaceuticals Launches with $23.5 Million Series A Financing for Novel Drug Discovery Targeting Cellular Nutrient Signaling to Treat Chronic Diseases and Rare Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Jun 2014
Titan Medical Inc. Announces Completion of Key Milestone in the Development of Its SPORT(TM) Surgical System
Devices Surgery
 HSMN NewsFeed - 23 May 2014
eNeura, Inc. Receives FDA Clearance for SpringTMS(R) Migraine Treatment Device
Devices Neurology FDA
 HSMN NewsFeed - 23 Apr 2014
Kala Pharmaceuticals Announces $22.5 Million Series B Financing
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 9 Apr 2014
Brainsway's Deep TMS System Will be Exclusively Marketed by Medison Pharma in Israel
Devices Neurology Distribution
 HSMN NewsFeed - 28 Mar 2014
aTyr Pharma Appoints David M. Weiner, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2014
St. Jude Medical Announces FDA Approvals of New Pacemakers
Devices Cardiology FDA
 HSMN NewsFeed - 10 Mar 2014
Intra-Cellular Therapies Announces the Appointment of Juan Sanchez, M.D., as Vice President of Corporate Communications and Investor Relations
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 19 Feb 2014
Smith & Nephew introduces the POLARSTEM(TM) cementless hip stem to the US market
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 18 Feb 2014
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Feb 2014
aTyr Pharma Appoints Frederic Chereau as President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jan 2014
Covidien Receives U.S. Food and Drug Administration Clearance for LigaSure(TM) Maryland Jaw
Devices Surgery FDA
 HSMN NewsFeed - 6 Jan 2014
Kala Pharmaceuticals Appoints Howard B. Rosen as Chairman of the Board of Directors
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 2 Jan 2014
AtriCure Completes Acquisition of Estech
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 17 Dec 2013
Boston Scientific Announces CE Mark Approval And First Implants Of Its Next-Generation X4 Quadripolar CRT-D Systems
Devices Cardiology Regulatory
 HSMN NewsFeed - 11 Dec 2013
Ethicon Receives 510(k) Clearance for New HARMONIC FOCUS(R)+ Shears with Adaptive Tissue Technology
Devices Surgery FDA
 HSMN NewsFeed - 2 Dec 2013
Forest to Acquire U.S. Marketing Rights to Saphris(R) (asenapine) from Merck
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 2 Dec 2013
Visterra Closes $8.1 Million Financing and Expands Executive Team to Accelerate Company Growth
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 21 Nov 2013
Megadyne(R) Announces Collaboration Agreement with ETHICON
Devices Surgery Distribution
 HSMN NewsFeed - 21 Nov 2013
Ethicon Announces Collaboration Agreement with MEGADYNE(R)
Devices Surgery Distribution
 HSMN NewsFeed - 21 Nov 2013
Forest Laboratories and Gedeon Richter Receive Complete Response Letter for Cariprazine
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Nov 2013
Ethicon Energy Launches ENSEAL(R) G2 Articulating at AAGL Global Congress on Minimally Invasive Gynecology
Devices Surgery Product Launch
 HSMN NewsFeed - 5 Nov 2013
First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Hot Flashes Now Available by Prescription in U.S. Pharmacies
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Oct 2013
Ethicon Receives 510(k) Clearance of Ear, Nose and Throat (ENT) Indication for ENSEAL(R) Tissue Sealers
Devices FDA
 HSMN NewsFeed - 28 Oct 2013
Ethicon Receives 510(k) Clearance for New HARMONIC ACE(R)+ 7 Shears with Advanced Hemostasis
Devices Surgery FDA
 HSMN NewsFeed - 14 Oct 2013
St. Jude Medical Announces Acquisition and CE Mark Approval of World's First Leadless Pacemaker
Devices Cardiology Regulatory
 HSMN NewsFeed - 3 Sep 2013
Lipella Pharmaceuticals Inc. Names David Lucchino to Board of Directors
Biopharmaceuticals Drug Delivery Urology Personnel
 HSMN NewsFeed - 3 Sep 2013
Arsanis Inc Closes $20 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Jul 2013
Alexza Pharmaceuticals Announces European Launch of ADASUVE(R) (Staccato(R) Loxapine)
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 15 Jul 2013
Visterra Appoints Brian Pereira, M.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jun 2013
St. Jude Medical Receives CE Mark Approval of MultiPoint Pacing CRT-D
Devices Cardiology Regulatory
 HSMN NewsFeed - 18 Jun 2013
Promising Mid-Term Results From Thoracoscopic Ablation of Persistent Atrial Fibrillation Presented at Meeting of International Society for Minimally Invasive Cardiothoracic Surgery
Devices Cardiology
 HSMN NewsFeed - 28 May 2013
Kala Pharmaceuticals Appoints Charles McDermott as Executive Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 May 2013
Elan Announces Transactions: Decisively Transforming the Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 May 2013
Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013
Devices Interventional Cardiology
 HSMN NewsFeed - 8 May 2013
Teva and Alexza Announce Teva’s License to Market ADASUVE(R) in the U.S.
Biopharmaceuticals Licensing
 HSMN NewsFeed - 30 Apr 2013
St. Jude Medical Announces CE Mark and Launch of First Quadripolar CRT Pacemaker
Devices Cardiology Regulatory Product Launch
 HSMN NewsFeed - 2 Apr 2013
BIND Therapeutics Appoints Gregory I. Berk, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2013
Acceleron Receives Two FDA Orphan Designations for ACE-536
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Mar 2013
Ethicon Receives 510(K) Clearance for ENSEAL(R) G2 Cordless
Devices Surgery FDA
 HSMN NewsFeed - 28 Feb 2013
Kala Pharmaceuticals Secures $11.5 Million in Series A Financing
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 21 Feb 2013
Alexza Receives Marketing Authorization for ADASUVE(R) (Staccato(R) Loxapine) in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 4 Feb 2013
Ethicon Receives 510(k) Clearance for ENSEAL(R) G2 Articulating Tissue Sealer
Devices Surgery FDA
 HSMN NewsFeed - 30 Jan 2013
Encision Launches Three New Products, Including the EM3 AEM(R) Monitor
Devices Monitoring Surgery Product Launch
 HSMN NewsFeed - 28 Jan 2013
Ocular Therapeutix, Inc. Closes on $23.8 Million Series D Extension
Devices Drug Delivery Ophthalmology Venture Capital
 HSMN NewsFeed - 22 Jan 2013
Physicians Report Successful Clinical Use of the DFINE STAR(TM) Tumor Ablation System in Malignant Lesions of the Spine
Devices Orthopaedic Neurosurgery Oncology
 HSMN NewsFeed - 14 Dec 2012
The CHMP Delivers a Positive Opinion Recommending Grant of Marketing Authorization for ADASUVE(R) (Staccato(R) Loxapine) in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Nov 2012
Kala Pharmaceuticals Appoints Dr. Bernard Gilly to Its Board of Directors
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 9 Nov 2012
Visterra Secures Financing From Gates Foundation and Omega to Close $26M Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Oct 2012
Richard Wolf Introduces the Smallest Bipolar Resectoscope on the Market
Devices Surgery
 HSMN NewsFeed - 17 Oct 2012
DelRey ENT Associates Enhances the Care and Comfort of Tonsillectomy Patients with Thermal Fusion Technology
Devices
 HSMN NewsFeed - 15 Oct 2012
Corcept Therapeutics Appoints Daniel M. Bradbury to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2012
Promedior Expands Series D Round of Financing to Total $24.5 Million to Advance Pipeline of Pentraxin-2 Therapeutics for Fibrotic Diseases
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 11 Oct 2012
Alma Lasers Receives FDA Clearance for PixelRF Breakthrough Technology in Skin Resurfacing
Devices Dermatology FDA
 HSMN NewsFeed - 10 Oct 2012
Genocea Closes $30 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Sep 2012
Boston Scientific to Acquire BridgePoint Medical, Inc.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 4 Sep 2012
Pulmatrix Appoints Robert Clarke, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Aug 2012
Wockhardt receives tentative US FDA approval for generic version of anti-psychotic drug Geodon(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 16 Aug 2012
First Cardiac Surgery with Domain Surgical FMwand Completed at Beaumont Hospital
Devices Surgery
 HSMN NewsFeed - 10 Aug 2012
Neuren Appoints Joseph Horrigan, M.D., as VP of Clinical Development and Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Aug 2012
Ethicon Endo-Surgery Receives 510(k) Clearance for New HARMONIC ACE(R)+ Shears with Adaptive Tissue Technology
Devices Surgery FDA
 HSMN NewsFeed - 25 Jul 2012
NuPathe Appoints Armando Anido as Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 17 Jul 2012
St. Jude Medical Announces Japanese Launch of Industry's First Small Quadripolar Technology to Treat Heart Failure
Devices Cardiology
 HSMN NewsFeed - 12 Jul 2012
Covidien Announces New Bipolar Resection Software Application for ForceTriad(TM) Energy Platform
Devices Urology Surgery
 HSMN NewsFeed - 12 Jul 2012
Kala Pharmaceuticals Appoints Guillaume Pfefer, PhD as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jun 2012
Seventh Sense Biosystems Appoints President and CEO and Closes $10 Million Series-A Financing
Devices Venture Capital Personnel
 HSMN NewsFeed - 22 May 2012
MagForce signs distribution agreement with leading Russian medical device distribution company DELRUS
Devices Oncology Distribution
 HSMN NewsFeed - 1 May 2012
Vessix Receives CE Mark For V2 Renal Denervation System(TM) For Treatment Of Hypertension
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 14 Mar 2012
Kala Pharmaceuticals Secures $6.2 Million in Additional Equity Financing
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 8 Mar 2012
The Radiosurgery Society(TM) Completes its First Scientific Meeting as an Independent Society
Devices Oncology
 HSMN NewsFeed - 8 Mar 2012
Viking Systems Exhibits at SAGES in San Diego
Devices Gastroenterology Surgery
 HSMN NewsFeed - 29 Feb 2012
Conceptus(R) Receives FDA Approval for Compatible Use of Hologic's NovaSure(R) with Essure(R) Inserts in Place
Devices
 HSMN NewsFeed - 28 Feb 2012
Forest Laboratories, Inc. and Gedeon Richter Plc. Announce Results from Two Positive Phase III Trials with the Investigational Antipsychotic Cariprazine for the Treatment of Schizophrenia
Biopharmaceuticals
 HSMN NewsFeed - 8 Feb 2012
Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase III Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
Biopharmaceuticals
 HSMN NewsFeed - 26 Jan 2012
Celgene to Acquire Avila Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Jan 2012
Cerulean Pharma Appoints Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Jan 2012
Medtronic Announces 510(k) Clearance for the Aquamantys SBS 5.0 Sheathed Bipolar Sealer for Spine Surgery
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 23 Dec 2011
Acceleron Secures $30M Private Financing
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 15 Dec 2011
Cerulean Pharma Closes $15 Million Series D Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 2 Dec 2011
Missouri Baptist Medical Center Physicians Are First in Missouri to Implant New Heart Failure Device
Devices Cardiology
 HSMN NewsFeed - 21 Nov 2011
Covidien Announces Definitive Agreement to Acquire BÂRRX Medical, Inc.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 9 Nov 2011
Systagenix Adds Two Members to Board of Directors
Devices Wound Care Personnel
 HSMN NewsFeed - 3 Nov 2011
Ventus Medical Appoints Two Senior Executives
Devices Personnel
 HSMN NewsFeed - 1 Nov 2011
joimax(R) Launches Numerous Innovations at NASS Chicago From November 2 - 4, 2011
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 1 Nov 2011
Boston Scientific Announces Schedule of Events at TCT Scientific Symposium
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Oct 2011
Medtronic Announces 510(k) Clearance for the Aquamantys(R)3 System with Combined Hemostatic Sealing and Cutting Functionality
Devices FDA
 HSMN NewsFeed - 12 Oct 2011
Neuralstem Receives Notice of Patent Allowance for Spinal Cord Delivery Platform
Regenerative Medicine Neurology
 HSMN NewsFeed - 10 Oct 2011
MagForce AG Announces Treatment of Recurrent Glioblastoma Patient with NanoTherm(R) Therapy
Devices Oncology
 HSMN NewsFeed - 19 Aug 2011
Verathon(R) Introduces the Heartscape 3D ECG System with 80-Lead Vest in Europe; Technology Provides More Complete Data to Help Diagnose Acute Myocardial Infarction (MI)
Devices Cardiology Monitoring
 HSMN NewsFeed - 15 Aug 2011
Pulmatrix Secures a $14 million Financing to Advance Clinical Programs in COPD and Cystic Fibrosis
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Aug 2011
Symmetry Medical to Acquire Olsen Medical
Devices Orthopaedic Surgery Mergers & Acquisitions
 HSMN NewsFeed - 28 Jul 2011
Polaris Group Doses First Patient in Pivotal Phase 3 Clinical Trial of Lead Therapeutic Candidate ADI-PEG 20 for the Treatment of Hepatocellular Carcinoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Jul 2011
TARIS Appoints Christopher Searcy as the Company’s Chief Business Officer
Biopharmaceuticals Urology Personnel
 HSMN NewsFeed - 20 Jul 2011
Ethicon Endo-Surgery Launches ENSEAL(R) G2 Super Jaw First Bi-Polar Advanced Energy Technology Designed to Improve Surgeon Confidence in Tissue Affect
Devices Surgery
 HSMN NewsFeed - 16 Jun 2011
Ethicon Endo-Surgery Introduces Innovative New Generator to Help Simplify Use of Advanced Energy Technology in the OR
Devices Surgery
 HSMN NewsFeed - 15 Jun 2011
Ethicon Endo-Surgery Launches ENSEAL(R) G2 Super Jaw
Devices Surgery
 HSMN NewsFeed - 14 Jun 2011
Neuralstem Updates ALS Clinical Trial Progress
Regenerative Medicine Neurology
 HSMN NewsFeed - 16 May 2011
BridgePoint Medical Announced 510(k) Clearance for an Expanded Indication to Treat Coronary Chronic Total Occlusions
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 16 May 2011
Neuronetics, Inc. Raises $30 Million in Series E Financing
Devices Neurology Venture Capital
 HSMN NewsFeed - 11 May 2011
Seventh Sense Biosystems Secures $4.5 Million of Two-Tranche $10 Million Extension of its Series A Financing
Devices Diagnostics Venture Capital
 HSMN NewsFeed - 9 May 2011
Alkermes to Merge with Elan Drug Technologies to Create Alkermes plc
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 May 2011
Boston Scientific Offers New CRT-D Warranty Program Covering Phrenic Nerve Stimulation
Devices Cardiology
 HSMN NewsFeed - 2 May 2011
Sorin Group Launches the VascuClear(TM) Endoscopic Vessel Harvesting System
Devices Interventional
 HSMN NewsFeed - 28 Apr 2011
Results Promising From U.K. Clinical Trial Investigating Sonablate HIFU as a Focal Treatment for Prostate Cancer
Devices Oncology
 HSMN NewsFeed - 13 Apr 2011
TARIS Closes $18.3 Million Series B Financing
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 31 Mar 2011
Microline Surgical Launches MiSeal(TM) Reposable Thermal Ligating System at SAGES 2011 Annual Meeting
Devices Surgery
 HSMN NewsFeed - 18 Mar 2011
Utah Medical Products, Inc. Acquires Femcare Group Limited
Devices Mergers & Acquisitions
 HSMN NewsFeed - 9 Mar 2011
Salient Surgical Technologies Settles Bovie Medical Patent Infringement Lawsuit
Devices Surgery Litigation
 HSMN NewsFeed - 4 Mar 2011
Bovie Medical Corporation Announces Settlement of Litigation with Salient Surgical and Medtronic
Devices Surgery Litigation
 HSMN NewsFeed - 28 Feb 2011
Arsanis, Inc Announces Series A Financing with OrbiMed Advisors, Polaris Venture Partners and SV Life Sciences
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Feb 2011
Pervasis Receives FDA Fast Track Status for Vascugel(R) to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis
Biopharmaceuticals Interventional FDA
 HSMN NewsFeed - 2 Feb 2011
Ocular Therapeutix, Inc. Completes Series D Financing to Support Phase II Sustained Drug Delivery Clinical Trials
Devices Drug Delivery Ophthalmology Venture Capital
 HSMN NewsFeed - 24 Jan 2011
Bausch & Lomb Storz(R) Ophthalmics Introduces Additions to Its Single-Use Vitreoretinal Instruments Line
Devices Ophthalmology
 HSMN NewsFeed - 24 Jan 2011
Clinical Data, Inc. Announces FDA Approval of Viibryd(TM) (vilazodone HCl) for Major Depressive Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Dec 2010
Synergetics USA Introduces Next Generation Electrosurgical Generator
Devices Surgery Neurosurgery Distribution
 HSMN NewsFeed - 6 Dec 2010
First U.S. Patient Treated with the Accu2i Percutaneous Microwave Tissue Ablation Device (pMTA)
Devices Oncology
 HSMN NewsFeed - 3 Dec 2010
St. Jude Medical Neurostimulation Study Demonstrates Sustained Improvement in Chronic Low Back Pain Symptoms and Quality of Life
Devices Neurology
 HSMN NewsFeed - 15 Nov 2010
Cerulean Pharma Inc. Closes $24 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Oct 2010
aTyr Pharma Secures $23M Financing From Top Tier Venture Investor
Biopharmaceuticals Venture Captial
 HSMN NewsFeed - 25 Oct 2010
Omeros Receives $20 Million from Vulcan Capital and $5 Million Grant Award from Washington State's Life Sciences Discovery Fund to Advance its GPCR Program
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Oct 2010
GI Dynamics Receives European CE Mark Approval for 12 Months of EndoBarrier(TM) Treatment of Type 2 Diabetes and Obesity; Announces U.K. Launch
Devices Gastroenterology Endocrinology Regulatory
 HSMN NewsFeed - 7 Oct 2010
Spectral Molecular Imaging, Inc. Introduces Its Early Melanoma Detection Device SkinSpect(TM)
Devices Oncology
 HSMN NewsFeed - 4 Oct 2010
Covidien Demonstrates Breakthroughs in Minimally Invasive Surgery and Soft Tissue Repair at 2010 American College of Surgeons Clinical Congress (ACS)
Devices Surgery
 HSMN NewsFeed - 4 Oct 2010
Estech Launches the COBRA Revolution(TM) Bipolar Clamp for Surgical Ablation
Devices Cardiology Surgery
 HSMN NewsFeed - 28 Sep 2010
AstraZeneca UK Receives Positive Decision For Seroquel XL(R)[Black Triangle Drug] (Quetiapine Prolonged Release) as an Add-On Treatment of Major Depressive Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 9 Sep 2010
Shire Expands Pipeline to Treat Orphan Muscle Diseases Through Collaboration With Acceleron Pharma
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 Sep 2010
GI Dynamics Announces New Data Showing Significant Weight Loss, Cardiovascular and Metabolic Improvements Following 12 Months of EndoBarrier Treatment
Devices Gastroenterology
 HSMN NewsFeed - 1 Sep 2010
GI Dynamics Announces Distribution Agreement with Elemental Healthcare for the EndoBarrier Gastrointestinal Liner
Devices Distribution
 HSMN NewsFeed - 19 Aug 2010
GI Dynamics Announces Key Executive Appointments in Preparation for European Launch of EndoBarrier Gastrointestinal Liner
Devices Gastroenterology Personnel
 HSMN NewsFeed - 16 Aug 2010
Selecta Biosciences Appoints Werner Cautreels, Ph.D., as Company's First CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Aug 2010
Darl Moreland Joins Alexza Pharmaceuticals as Vice President, Quality
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Aug 2010
Genocea Biosciences Hires Chip Clark as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Aug 2010
Labopharm announces U.S. launch of OLEPTRO(TM) for treatment of major depressive disorder in adults
Biopharmaceuticals
 HSMN NewsFeed - 2 Aug 2010
Sagent Pharmaceuticals Announces Two New FDA Approvals: Sumatriptan Succinate Injection and Rocuronium Bromide Injection
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Jul 2010
Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jul 2010
TARIS Appoints Sarma Duddu as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jul 2010
BARRX Medical, Inc. Completes $15 Million Growth Financing
Devices Gastroenterology Venture Capital
 HSMN NewsFeed - 14 Jul 2010
Trevena Secures $35 Million in Series B Funding to Progress Portfolio of GPCR Biased Ligands and to Complete Phase 2 Study of TRV120027 for Acute Heart Failure
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Jun 2010
BIND Biosciences Secures $12.4 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Jun 2010
BIND Biosciences Appoints Ed Schnipper, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jun 2010
Boston Scientific Expands PolarCath(R) Peripheral Dilatation System With New Balloon Sizes
Devices Interventional
 HSMN NewsFeed - 14 Jun 2010
AtriCure's AtriClip System Receives FDA 510(k) Clearance
Devices Cardiology FDA
 HSMN NewsFeed - 14 Jun 2010
aTyr Pharma Appoints Catharine E. Johnson As Senior Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jun 2010
New Data at ASCO Show Novartis Drug Tasigna(R) Surpasses Gleevec(R) for Newly Diagnosed CML Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jun 2010
Apnex Medical, Inc. Names Chas McKhann President, Chief Executive Officer
Devices Neurology Personnel
 HSMN NewsFeed - 26 May 2010
Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten Minutes After Dosing in Patients with Schizophrenia or Bipolar Disorder
Biopharmaceuticals
 HSMN NewsFeed - 25 May 2010
Dr. John Mendlein Joins aTyr Pharma as Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 May 2010
Epizyme Appoints Mikel Moyer, Ph.D., Vice President of Molecular Discovery
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 May 2010
St. Jude Medical Announces European Launch of Industry's First Quadripolar Pacing System
Devices Cardiology
 HSMN NewsFeed - 11 May 2010
Solta Medical and Alma Lasers Resolve Patent Lawsuits
Devices Litigation
 HSMN NewsFeed - 28 Apr 2010
Konica Minolta Opto, Inc. Extends Product Development Licensing Agreement with Guided Therapeutics
Devices Diagnostics Oncology Licensing
 HSMN NewsFeed - 15 Apr 2010
Exactech Approved to Begin Marketing Novation(R) Hip System in High Demand Asian Market
Devices Orthopaedic Regulatory
 HSMN NewsFeed - 14 Apr 2010
Salient Surgical Brings the Benefits of TRANSCOLLATION(TM) Technology to the Orthopedic Trauma Market
Devices Surgery Orthopaedic
 HSMN NewsFeed - 13 Apr 2010
MicroCHIPS Taps Medical Industry Veteran as Next CEO
Devices Personnel
 HSMN NewsFeed - 5 Apr 2010
Selecta Closes $15 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Mar 2010
Megadyne Introduces the ACE Blade, the Safe and Effective Cutting Device
Devices Surgery
 HSMN NewsFeed - 19 Mar 2010
Bovie Medical Corporation Announces Clearance to Market Its BOSS Soft Tissue Coagulation Device
Devices Surgery FDA
 HSMN NewsFeed - 16 Mar 2010
Promedior Closes $12 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Mar 2010
Integra LifeSciences Introduces Four New Products at the Association of periOperative Registered Nurses (AORN) Conference
Devices Surgery
 HSMN NewsFeed - 12 Mar 2010
Bovie Medical Corporation Announces Clearance to Market Its ICON VS Electrosurgical Generator
Devices Surgery FDA
 HSMN NewsFeed - 11 Mar 2010
Illumina and Glenn Close Announce the First Full Coverage DNA Sequencing of a Named Female
Diagnostics
 HSMN NewsFeed - 10 Mar 2010
Cerulean Pharma Inc. Appoints Two Senior Executives to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Mar 2010
OrthoDynamix LLC Receives FDA 510(k) Clearance for ArthroSteer(R) 3.5mm Ablator
Devices Orthopaedic Surgery FDA
 HSMN NewsFeed - 22 Feb 2010
Syneron Receives FDA Clearance for Expanded Indications of eMatrix(TM) Sublative Rejuvenation System
Devices FDA
 HSMN NewsFeed - 19 Feb 2010
Novartis Drug Tasigna(R) Receives FDA Priority Review for Newly Diagnosed Patients With Early-Stage Chronic Myeloid Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Feb 2010
Cymbalta(R) Significantly Reduced Chronic Low Back Pain in New Study
Biopharmaceuticals
 HSMN NewsFeed - 3 Feb 2010
Silodosin (Urorec(R)/Silodyx) Approved by the European Commission for the Treatment of the Signs and Symptoms of BPH (Benign Prostatic Hyperplasia)
Biopharmaceuticals Urology Regulatory
 HSMN NewsFeed - 2 Feb 2010
Guided Therapeutics, Inc. Receives New Funding Commitment from Konica Minolta Opto, Inc. to Expand Cancer Detection Product Line
Devices Diagnostics Oncology
 HSMN NewsFeed - 1 Feb 2010
Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Jan 2010
BIND Biosciences, Inc. closes $11 M Series C financing round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Jan 2010
GI Dynamics Receives Strategic Investment from Medtronic, Inc.
Devices Gastroenterology Venture Capital
 HSMN NewsFeed - 5 Jan 2010
Corcept Therapeutics Announces Four Anticipated Milestones for 2010
Biopharmaceuticals
 HSMN NewsFeed - 5 Jan 2010
NewCardio, Inc. Announces Successful Clinical Studies Validating CardioBip Technology
Devices Cardiology Monitoring
 HSMN NewsFeed - 22 Dec 2009
GI Dynamics Receives European CE Mark Approval for the EndoBarrier Gastrointestinal Liner System for the Treatment of Type 2 Diabetes and Obesity
Devices Gastroenterology Regulatory
 HSMN NewsFeed - 22 Dec 2009
Acceleron Pharma Expands Management Team with Two New Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2009
FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Dec 2009
Fresenius Medical Care Announces Management Board Changes
Devices Personnel
 HSMN NewsFeed - 8 Dec 2009
Novartis Tasigna(R) Trial Shows Superior Results to Gleevec(R) in Patients With Early-Stage Chronic Myeloid Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Dec 2009
FDA Approves Lilly's Zyprexa for Two Adolescent Indications
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Dec 2009
US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Dec 2009
Apnex Medical, Inc. Raises Additional $14 Million
Devices Venture Capital
 HSMN NewsFeed - 30 Nov 2009
FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Nov 2009
BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 20 Nov 2009
Pfizer Receives FDA Approval For Geodon(R) (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Nov 2009
Synergetics USA, Inc. Announces Addendum to Marketing Partner Agreement with Codman & Shurtleff, Inc. for Disposable Bipolar Forceps
Devices Neurosurgery Distribution
 HSMN NewsFeed - 16 Nov 2009
Fate Therapeutics Closes $30 Million Series B Financing
Regenerative Medicine Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Nov 2009
Acceleron Pharma Initiates First-in-Human Study of ACE-041, a Novel Angiogenesis Inhibitor, in Patients with Advanced Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Nov 2009
AtriCure Announces Tentative Settlement with the Department of Justice
Devices Cardiology Litigation
 HSMN NewsFeed - 20 Oct 2009
Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Oct 2009
AtriCure Announces European Approval for its AtriClip System
Devices Cardiology Regulatory
 HSMN NewsFeed - 5 Oct 2009
FDA Advisory Committee Recommends Approval of PEGINTRON(R) for the Adjuvant Treatment of Stage III Malignant Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Oct 2009
Ocular Therapeutix, Inc. Appoints Two New Board Members
Devices Ophthalmology Personnel
 HSMN NewsFeed - 16 Sep 2009
Medtronic Launches New and Innovative Intraoperative Nerve Integrity Monitors for Surgeons
Devices Monitoring Surgery
 HSMN NewsFeed - 16 Sep 2009
Pervasis Therapeutics Announces $17 Million in Financing and New Board Member
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 14 Sep 2009
Schering-Plough Reports Data From SAPHRIS(R) (asenapine) Long-Term Schizophrenia Relapse Prevention Study
Biopharmaceuticals
 HSMN NewsFeed - 11 Sep 2009
New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Cymbalta(R)
Biopharmaceuticals
 HSMN NewsFeed - 9 Sep 2009
Syneron Medical Ltd. and Candela Corporation to Merge Creating a Leading Global Aesthetic Device Company
Devices Mergers & Acquisitions
 HSMN NewsFeed - 29 Jul 2009
Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jul 2009
Cerulean Pharma Inc. Closes $10 Million Series B-1 Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Jul 2009
aTyr Pharma Raises an Additional $12 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Jul 2009
Avila Therapeutics, Inc. Closes $30 Million Series B Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 24 Jul 2009
SAPHRIS(R) (asenapine) Meets Primary Endpoint in Long-Term Extension Study in Patients With Predominant, Persistent Negative Symptoms of Schizophrenia
Biopharmaceuticals
 HSMN NewsFeed - 22 Jul 2009
Bovie Medical Corporation Announces 510(k) Submissions to the FDA for Its Seal-N-Cut Vessel Sealing Instruments
Devices Surgery FDA
 HSMN NewsFeed - 1 Jul 2009
Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment
Biopharmaceuticals
 HSMN NewsFeed - 19 Jun 2009
I-Therapeutix, Inc. Closes $15 Million Financing
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 19 Jun 2009
Covidien Features New Devices for Minimally Invasive Surgery and Soft Tissue Repair at ASMBS 2009
Devices Surgery
 HSMN NewsFeed - 3 Jun 2009
Ethicon Endo-Surgery Studies Presented at DDW Demonstrate Potential of Pure NOTES Surgery With Company's Toolbox
Devices Surgery
 HSMN NewsFeed - 2 Jun 2009
Schering-Plough Announces European Filing of SYCREST(R) (asenapine) for the Treatment of Schizophrenia and Bipolar I Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 1 Jun 2009
Cephalon Announces the Availability of NUVIGIL for the Treatment of Excessive Sleepiness Associated with Treated Obstructive Sleep Apnea, Shift Work Disorder and Narcolepsy
Biopharmaceuticals
 HSMN NewsFeed - 26 May 2009
FDA Grants Full Approval for SPRYCEL (dasatinib) for the Treatment of Adults with Chronic Myeloid Leukemia Who Are Resistant or Intolerant to Prior Therapies Including Gleevec*
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 May 2009
FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 May 2009
Avila Therapeutics Appoints Katrine S. Bosley as Company's First CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 May 2009
Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 May 2009
FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 11 May 2009
Eurand Announces FDA Approval of EUR-1048 (Lamictal(R) ODT(TM)), Co-Developed With GlaxoSmithKline
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 5 May 2009
Pervasis Therapeutics Granted Orphan Drug Designation for Vascugel
Biopharmaceuticals Regenerative Medicine FDA
 HSMN NewsFeed - 30 Apr 2009
Cardica Develops the Cardica Microcutter, The First True Multi-Fire Endolinear Cutter
Devices Surgery
 HSMN NewsFeed - 20 Apr 2009
Microline PENTAX Acquires Starion Instruments
Devices Acquisitions
 HSMN NewsFeed - 20 Apr 2009
Syneron Medical Moves Forward in Shift Toward Recurring Revenue Models in Response to New Market Environment
Devices
 HSMN NewsFeed - 8 Apr 2009
Cerulean Pharma Inc. Announces Appointment of Oliver S. Fetzer as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Apr 2009
Aplenzin(TM), the Only Single Tablet Once-Daily Treatment for Depression at All Doses, Now Available in the United States
Biopharmaceuticals
 HSMN NewsFeed - 31 Mar 2009
Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD
Biopharmaceuticals
 HSMN NewsFeed - 27 Mar 2009
AtriCure's Cryoablation System, Cryo1, Receives FDA 510(k) Clearance
Devices Cardiology FDA
 HSMN NewsFeed - 23 Mar 2009
FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Mar 2009
Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 17 Mar 2009
Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
Biopharmaceuticals
 HSMN NewsFeed - 16 Mar 2009
Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Mar 2009
FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Mar 2009
BridgePoint Medical Completes First U.S. Clinical Case Using CrossBoss and Stingray Devices in CTO Angioplasty Procedure
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Mar 2009
Merck and Schering-Plough to Merge
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Feb 2009
Salient Surgical Technologies Launches New Advanced Energy Device Designed to Improve Patient Outcomes in Spine Surgery
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 25 Feb 2009
Selecta Biosciences, Inc. Closes $15.1M Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Feb 2009
Hydromer, Inc. Announces Sale of Product Lines to Merit Medical Systems, Inc.
Devices Acquisitions
 HSMN NewsFeed - 24 Feb 2009
CHMP delays European Commission decision process to approve ZEVTERA(TM)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Feb 2009
AstraZeneca Announces SEROQUEL XR is Now Available to Treat Bipolar Depression
Biopharmaceuticals
 HSMN NewsFeed - 20 Feb 2009
Schering-Plough Submits Response to FDA for SAPHRIS(TM) (asenapine) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder
Biopharmaceuticals
 HSMN NewsFeed - 19 Feb 2009
GI Dynamics Closes an Additional $15 Million in Series C Financing
Devices Venture Capital
 HSMN NewsFeed - 17 Feb 2009
Syneron(TM) Partners With the American Academy of Cosmetic Physicians (AAOCP) to Train LipoLite(TM) and Laser LipoSculpture Physicians
Devices
 HSMN NewsFeed - 12 Feb 2009
Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Feb 2009
Genocea Biosciences Names Jane Halpern Vice President of Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Feb 2009
FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Feb 2009
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Feb 2009
Syneron Medical Announces Management Change to Support Strengthening of Syneron's Leadership Position in a Challenging Professional Aesthetic Market
Devices Personnel
 HSMN NewsFeed - 29 Jan 2009
Alexza Consolidates Operations to Focus Resources on AZ-004 (Staccato(R) Loxapine) for Acute Agitation
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 28 Jan 2009
Mylan Receives Final FDA Approvals for Generic Versions of Lamictal(R) Tablets and Lamictal(R) CD
Biopharmaceuticals Generics Neurology FDA
 HSMN NewsFeed - 27 Jan 2009
Schering-Plough Completes Enrollment of Boceprevir Registration Studies in Treatment-Naive and Treatment-Experienced HCV Patients
Biopharmaceuticals
 HSMN NewsFeed - 22 Jan 2009
Cardo Medical Announces the Initial Release of Its Press-Fit Total Hip System
Devices Orthopaedic
 HSMN NewsFeed - 16 Jan 2009
Hydra Biosciences Raises $22 Million in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Jan 2009
Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices
Biopharmaceuticals
 HSMN NewsFeed - 14 Jan 2009
U.S. FDA Issues Complete Response Letter for SAPHRIS(TM) (ASENAPINE) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2009
Synergetics USA, Inc. Announces Three Month Extension of Current Agreements with Codman & Shurtleff, Inc. as Longer Term Agreement Negotiations Continue
Devices Neurosurgery Licensing
 HSMN NewsFeed - 7 Jan 2009
Marshall Edwards, Inc. Granted IND for Triphendiol
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Nov 2008
Adimab, Inc. Announces Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Oct 2008
Bovie Medical Corporation Announces CE Mark and Submission of 510(K) Application for SEER Tissue Resection Device; Commences SEER Shipments in European Union
Devices Regulatory FDA
 HSMN NewsFeed - 21 Oct 2008
Pervasis Therapeutics Appoints Life Sciences Industry Executive Frederic Chereau as Company's President and Chief Executive Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 17 Oct 2008
T2 Biosystems Raises $10.8 Million in Series B Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 10 Oct 2008
FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Oct 2008
Archus Orthopedics Performs First Facet Replacement Procedure With an Artificial Disc
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 8 Oct 2008
FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression
Devices Neurology FDA
 HSMN NewsFeed - 7 Oct 2008
Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
Biopharmaceuticals
 HSMN NewsFeed - 7 Oct 2008
Eli Lilly and Company Resolves Investigation Involving Numerous States
Biopharmaceuticals
 HSMN NewsFeed - 6 Oct 2008
Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron(R) in Hepatitis C
Biopharmaceuticasl Venture Capital
 HSMN NewsFeed - 26 Sep 2008
GI Dynamics Announces Promising Multi-Center Safety and Efficacy Data of EndoBarrier(TM) Gastrointestinal Liner for Pre-Surgical Weight Loss
Devices
 HSMN NewsFeed - 26 Sep 2008
CHMP Recommends Approval of Olanzapine Long-acting Injection for Maintenance Treatment of Schizophrenia in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Sep 2008
New Studies Highlight Benefits of Coblation(R)-Assisted Procedures in Airway Fire Prevention and Endoscopic Sinus Surgery
Devices Surgery
 HSMN NewsFeed - 23 Sep 2008
Syneron(TM) Receives FDA Clearance for Versatile Matrix RF(TM) Fractional Ablative Applicator
Devices Dermatology FDA
 HSMN NewsFeed - 19 Sep 2008
Syneron Receives European CE Mark for Versatile Matrix RF(TM) Fractional Ablative Applicator
Devices Dermatology Regulatory
 HSMN NewsFeed - 16 Sep 2008
Mylan Receives FDA Approval for Generic Version of Anti-Psychotic Risperdal(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 2 Sep 2008
Catheter Ablation System for Atrial Fibrillation Shows Reduced Procedure Time, Remarkable Safety Profile and Excellent Outcomes in Two Clinical Studies
Devices Cardiology
 HSMN NewsFeed - 2 Sep 2008
CSMG Technologies Subsidiary Live Tissue Connect Awarded European Union CE Mark Certificate; Follows Recent U.S. FDA Clearance
Devices Regulatory
 HSMN NewsFeed - 25 Aug 2008
Noven Provides Update on Daytrana(R) Methylphenidate Transdermal System
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 12 Aug 2008
Follica Announces $11M in New Financing and Expanded Team
Devices Personnel Venture Capital
 HSMN NewsFeed - 5 Aug 2008
Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Aug 2008
Bovie Medical Corporation Announces FDA Clearance for Sale and Marketing of Its MEG Laparoscopic Line
Devices FDA
 HSMN NewsFeed - 31 Jul 2008
Sierra Neuropharmaceuticals Completes $21.5-Million Series A Funding Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Jul 2008
Noven Announces Final FDA Approval of Stavzor(TM) for the Treatment of Bipolar Disorder, Seizures and Migraine Headaches
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Jul 2008
Banner Pharmacaps Receives FDA Approval for Valproic Acid Delayed Release Softgel Capsules
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 23 Jul 2008
Vaccine Executive Staph Bakali Joins Genocea Biosciences' Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jul 2008
Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President, Global Supply Chain and Sustainment Engineering
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jul 2008
Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day
Biopharmaceuticals
 HSMN NewsFeed - 24 Jun 2008
Studies of an Innovative Catheter Ablation System for Atrial Fibrillation Reveal Excellent Outcomes, Safety Profile and Fast Procedure Times
Devices Cardiology
 HSMN NewsFeed - 11 Jun 2008
CeNeRx BioPharma Appoints Mahnaz Asgharnejad as Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jun 2008
Syneron Signs Multi-Year Exclusive Equipment Provider Agreement with Sono Bello Contouring Centers to Offer LipoLite(TM) and VelaShape(TM)
Devices Dermatology
 HSMN NewsFeed - 9 Jun 2008
Noven Provides Update on Daytrana(TM) Methylphenidate Transdermal System
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 29 May 2008
Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 May 2008
Data Show Rufinamide, an Investigational Adjunctive Treatment for Lennox- Gastaut Syndrome, Reduced Drop Attacks by More Than 40%
Biopharmaceuticals Neurology
 HSMN NewsFeed - 19 May 2008
Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 May 2008
Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies
Biopharmaceuticals
 HSMN NewsFeed - 14 May 2008
Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 May 2008
St. Jude Medical Announces Launch of New Circular Mapping Catheter
Devices Cardiology
 HSMN NewsFeed - 14 May 2008
FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 May 2008
FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 May 2008
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
Biopharmaceuticals
 HSMN NewsFeed - 7 May 2008
Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources
Biopharmaceuticals
 HSMN NewsFeed - 5 May 2008
GE Healthcare Signs Global Molecular Diagnostic Agreement to Advance Respiratory Drug Development
Biopharmaceuticals Radiology Licensing
 HSMN NewsFeed - 1 May 2008
Syneron's LipoLite(TM) Minimally Invasive Laser-Assisted Lypolysis Receives FDA Clearance
Devices Dermatology FDA
 HSMN NewsFeed - 23 Apr 2008
FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Apr 2008
First Human Implant of New Archus Orthopedics Facet Replacement System
Devices Orthopaedic
 HSMN NewsFeed - 10 Apr 2008
Covidien Unveils the Next Generation in Advanced Surgery
Devices Surgery
 HSMN NewsFeed - 8 Apr 2008
Bristol-Myers Squibb and Otsuka Receive European Marketing Authorisation for ABILIFY(R) in the Treatment and Prevention of Moderate to Severe Manic Episodes in Bipolar I Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Mar 2008
AtriCure's Coolrail(TM) Linear Ablation Pen Receives FDA 510(k) Clearance
Devices Cardiology FDA
 HSMN NewsFeed - 12 Mar 2008
Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
Biopharmaceuticals
 HSMN NewsFeed - 11 Mar 2008
FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Mar 2008
Carl Zeiss Meditec Introduces New Humphrey Field Analyzer for Glaucoma Management and Blindness Prevention
Devices Ophthalmology
 HSMN NewsFeed - 5 Mar 2008
Trevena, Inc. Announces $24 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Mar 2008
FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Feb 2008
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Feb 2008
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
Biopharmaceuticals
 HSMN NewsFeed - 28 Feb 2008
Hatch Medical to Broker Chronic Total Occlusion Device
Devices Interventional
 HSMN NewsFeed - 28 Feb 2008
FDA Issues Not-Approvable Letter for Lilly's Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Feb 2008
Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Feb 2008
Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Biopharmaceuticals
 HSMN NewsFeed - 11 Feb 2008
AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy(TM) Bipolar Ablation System to Treat Atrial Fibrillation
Devices Cardiology
 HSMN NewsFeed - 7 Feb 2008
AtriCure Appoints Mark A. Collar to its Board of Directors
Devices Personnel
 HSMN NewsFeed - 6 Feb 2008
FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Feb 2008
Promedior Adds to Management Team and Announces Extension of Series A Financing
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 1 Feb 2008
Thermage Introduces Cellulite Product
Devices Dermatology
 HSMN NewsFeed - 31 Jan 2008
Syneron(TM) Previews Matrix RF(TM) Ablative Fractional Device and Laser-Assisted Lipolysis System at American Academy of Dermatology Annual Meeting
Devices Dermatology
 HSMN NewsFeed - 31 Jan 2008
Starion Achieves Worldwide Distribution of Proprietary Tissue Welding Technology
Devices Surgery
 HSMN NewsFeed - 18 Jan 2008
In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
Biopharmaceuticals
 HSMN NewsFeed - 18 Jan 2008
Pfizer Statement on CHANTIX (varenicline) Labeling Update in the United States
Biopharmaceuticals
 HSMN NewsFeed - 16 Jan 2008
CSMG Technologies Announces Frank D'Amelio to Become President and Board Member of its Subsidiary Live Tissue Connect, Inc.
Devices Personnel
 HSMN NewsFeed - 15 Jan 2008
Pervasis Therapeutics Closes Additional $9.75 Million in Financing
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 14 Jan 2008
Surgeons and Electrophysiologist Publish Positive Data Using AtriCure Minimally Invasive Products
Devices Cardiology
 HSMN NewsFeed - 3 Jan 2008
FDA Approves Additional Dosage Strengths of Shire's ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Jan 2008
Tempo Pharmaceuticals Closes $8 Million in Series B Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Jan 2008
Syneron Announces R&D Management Transition
Devices Personnel
 HSMN NewsFeed - 26 Dec 2007
Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed Release Capsules
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Dec 2007
Cardiac Dimensions(R) Inc. Announces Closing of $35.5 Million Round of Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 13 Dec 2007
FDA Advisory Panel Finds Hologic's Adiana(R) Permanent Contraception Approvable
Devices FDA
 HSMN NewsFeed - 12 Dec 2007
INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia
Biopharmaceuticals
 HSMN NewsFeed - 27 Nov 2007
Valeant Pharmaceuticals Completes Enrollment of Second Pivotal Phase 3 Trial for Epilepsy Drug Retigabine
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Nov 2007
BIND Biosciences, Inc. Closes $16M Series B Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Nov 2007
Synergetics USA, Inc. Adds New Electrosurgical Generator to Its Neurosurgical Product Line
Devices Neurosurgery
 HSMN NewsFeed - 20 Nov 2007
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Disorder (MDD)
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Nov 2007
SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Nov 2007
ABILIFY(R) (aripiprazole) Supplemental New Drug Application for the Treatment of Pediatric Patients with Bipolar I Disorder Accepted for Priority Review by the U.S. Food and Drug Administration
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Nov 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lamictal(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 9 Nov 2007
Synergetics Announces a New Executive Vice President of Sales and Marketing
Devices Personnel
 HSMN NewsFeed - 8 Nov 2007
FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML
Biopharmaceuticals FDA Oncology
 HSMN NewsFeed - 6 Nov 2007
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Nov 2007
Network Formed to Tackle Cardiac Safety Challenge
Devices Cardiology
 HSMN NewsFeed - 1 Nov 2007
ArthroCare Launches New, Intelligent Controller and Upgraded Coblation Wands to Enable Advanced Arthroscopic Surgery
Devices Surgery
 HSMN NewsFeed - 30 Oct 2007
Synergetics USA, Inc. Adds "Energy BurstTM" to Malis(R) AdvantageTM Electrosurgical Generator
Devices Surgery
 HSMN NewsFeed - 30 Oct 2007
Acceleron Pharma Completes $31M Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Oct 2007
Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Oct 2007
New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo
Biopharmaceuticals
 HSMN NewsFeed - 25 Oct 2007
Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting
Biopharmaceuticals
 HSMN NewsFeed - 23 Oct 2007
FDA Issues Approvable Letter for Stavzor(TM) Delayed Release Valproic Acid Capsules
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 15 Oct 2007
New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Oct 2007
Immersion Medical Introduces OB/GYN Module for LaparoscopyVR(TM) Surgical Simulator
Devices Surgery
 HSMN NewsFeed - 5 Oct 2007
Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
Biopharmaceuticals
 HSMN NewsFeed - 3 Oct 2007
Dr. Michael Jolley Joins Cytocore as Director of Assay Development
Diagnostics Personnel
 HSMN NewsFeed - 24 Sep 2007
Bristol-Myers Squibb to Acquire Adnexus Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Sep 2007
Acceleron Pharma Appoints Niels Borgstein, M.D. as Vice President, Medical Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Sep 2007
Robert S. Fishman, MD, FCCP Joins Alexza as Vice President, Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Sep 2007
NDO Receives FDA 510(K) Clearance for Plicator II(TM)
Devices Gastroenterology FDA
 HSMN NewsFeed - 18 Sep 2007
Acceleron Pharma Appoints John L. Knopf, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Sep 2007
Phreesia Secures $10.25M Series B Funding
Devices Venture Capital
 HSMN NewsFeed - 11 Sep 2007
Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 10 Sep 2007
AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
Devices Cardiology
 HSMN NewsFeed - 7 Sep 2007
Statement of Eli Lilly and Company on Dr. David Egilman Settlement
Biopharmaceuticals Litigation
 HSMN NewsFeed - 5 Sep 2007
UltraShape Secures $15.1 Million in New Financing Led by Meritech Capital
Devices Venture Capital
 HSMN NewsFeed - 4 Sep 2007
Noven Provides Update on Daytrana(TM) Methylphenidate Transdermal System
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 4 Sep 2007
Shire Voluntarily Withdraws a Limited Portion of DAYTRANA(TM) (Methylphenidate Transdermal System) Patches
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 30 Aug 2007
Archus Orthopedics Completes World's First Lumbosacral Facet Joint Replacement
Devices Orthopaedic
Return to NewsFeed  

 Additional items found! 326

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 326 additional stories matching:
POLAR
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.